Autoimmunity and immunodeficiency associated with monoallelic LIG4 mutations via haploinsufficiency.

DNA damage–autoimmunity DNA ligase 4 autosomal dominant haploinsufficiency immunodeficiency inborn errors of immunity primary immunodeficiency

Journal

The Journal of allergy and clinical immunology
ISSN: 1097-6825
Titre abrégé: J Allergy Clin Immunol
Pays: United States
ID NLM: 1275002

Informations de publication

Date de publication:
08 2023
Historique:
received: 28 03 2022
revised: 24 02 2023
accepted: 06 03 2023
pmc-release: 01 02 2024
medline: 7 8 2023
pubmed: 3 4 2023
entrez: 2 4 2023
Statut: ppublish

Résumé

Biallelic mutations in LIG4 encoding DNA-ligase 4 cause a rare immunodeficiency syndrome manifesting as infant-onset life-threatening and/or opportunistic infections, skeletal malformations, radiosensitivity and neoplasia. LIG4 is pivotal during DNA repair and during V(D)J recombination as it performs the final DNA-break sealing step. This study explored whether monoallelic LIG4 missense mutations may underlie immunodeficiency and autoimmunity with autosomal dominant inheritance. Extensive flow-cytometric immune-phenotyping was performed. Rare variants of immune system genes were analyzed by whole exome sequencing. DNA repair functionality and T-cell-intrinsic DNA damage tolerance was tested with an ensemble of in vitro and in silico tools. Antigen-receptor diversity and autoimmune features were characterized by high-throughput sequencing and autoantibody arrays. Reconstitution of wild-type versus mutant LIG4 were performed in LIG4 knockout Jurkat T cells, and DNA damage tolerance was subsequently assessed. A novel heterozygous LIG4 loss-of-function mutation (p.R580Q), associated with a dominantly inherited familial immune-dysregulation consisting of autoimmune cytopenias, and in the index patient with lymphoproliferation, agammaglobulinemia, and adaptive immune cell infiltration into nonlymphoid organs. Immunophenotyping revealed reduced naive CD4 This study provides evidence that certain monoallelic LIG4 mutations may cause human immune dysregulation via haploinsufficiency.

Sections du résumé

BACKGROUND
Biallelic mutations in LIG4 encoding DNA-ligase 4 cause a rare immunodeficiency syndrome manifesting as infant-onset life-threatening and/or opportunistic infections, skeletal malformations, radiosensitivity and neoplasia. LIG4 is pivotal during DNA repair and during V(D)J recombination as it performs the final DNA-break sealing step.
OBJECTIVES
This study explored whether monoallelic LIG4 missense mutations may underlie immunodeficiency and autoimmunity with autosomal dominant inheritance.
METHODS
Extensive flow-cytometric immune-phenotyping was performed. Rare variants of immune system genes were analyzed by whole exome sequencing. DNA repair functionality and T-cell-intrinsic DNA damage tolerance was tested with an ensemble of in vitro and in silico tools. Antigen-receptor diversity and autoimmune features were characterized by high-throughput sequencing and autoantibody arrays. Reconstitution of wild-type versus mutant LIG4 were performed in LIG4 knockout Jurkat T cells, and DNA damage tolerance was subsequently assessed.
RESULTS
A novel heterozygous LIG4 loss-of-function mutation (p.R580Q), associated with a dominantly inherited familial immune-dysregulation consisting of autoimmune cytopenias, and in the index patient with lymphoproliferation, agammaglobulinemia, and adaptive immune cell infiltration into nonlymphoid organs. Immunophenotyping revealed reduced naive CD4
CONCLUSIONS
This study provides evidence that certain monoallelic LIG4 mutations may cause human immune dysregulation via haploinsufficiency.

Identifiants

pubmed: 37004747
pii: S0091-6749(23)00422-0
doi: 10.1016/j.jaci.2023.03.022
pmc: PMC10529397
mid: NIHMS1915164
pii:
doi:

Substances chimiques

DNA Ligases EC 6.5.1.-
DNA Ligase ATP EC 6.5.1.1
DNA 9007-49-2
LIG4 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

500-516

Subventions

Organisme : Intramural NIH HHS
ID : ZIA AI001222
Pays : United States

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3024-9
pubmed: 20133615
Front Immunol. 2020 Aug 06;11:1734
pubmed: 32849618
Haematologica. 2015 Jan;100(1):42-8
pubmed: 25239263
Br J Radiol. 1990 Aug;63(752):624-8
pubmed: 2400879
DNA Repair (Amst). 2019 Oct;82:102686
pubmed: 31476573
Orphanet J Rare Dis. 2007 Jan 15;2:5
pubmed: 17224058
Pediatr Blood Cancer. 2009 Sep;53(3):482-4
pubmed: 19418549
Nat Protoc. 2009;4(7):1073-81
pubmed: 19561590
Eur J Med Genet. 2020 Sep;63(9):103974
pubmed: 32534991
Front Pediatr. 2019 Jan 21;6:426
pubmed: 30719430
J Allergy Clin Immunol. 2008 Dec;122(6):1219-20
pubmed: 18845326
Pediatr Allergy Immunol. 2017 Mar;28(2):203-206
pubmed: 27893162
Curr Allergy Asthma Rep. 2020 Jul 9;20(10):57
pubmed: 32648006
Hum Mol Genet. 2015 Jul 1;24(13):3708-17
pubmed: 25839420
Nature. 2019 Oct;574(7776):122-126
pubmed: 31554970
J Allergy Clin Immunol. 2017 Mar;139(3):1043-1046.e5
pubmed: 27908448
Nat Rev Immunol. 2016 Apr;16(4):234-46
pubmed: 26996199
Nature. 1998 Nov 12;396(6707):173-7
pubmed: 9823897
Front Mol Biosci. 2020 Apr 28;7:58
pubmed: 32411719
Ann Allergy Asthma Immunol. 2017 Oct;119(4):379-380
pubmed: 28866308
Hum Mutat. 2014 Jan;35(1):76-85
pubmed: 24123394
Clin Immunol. 2016 Feb;163:108-10
pubmed: 26774591
Nat Immunol. 2019 Oct;20(10):1311-1321
pubmed: 31527833
J Clin Immunol. 2020 Nov;40(8):1187-1190
pubmed: 32914283
Front Immunol. 2021 Sep 24;12:695993
pubmed: 34630384
J Clin Immunol. 2016 May;36(4):341-53
pubmed: 27063650
Sci Rep. 2016 Mar 11;6:22878
pubmed: 26964677
Nat Rev Mol Cell Biol. 2017 Aug;18(8):495-506
pubmed: 28512351
DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1227-35
pubmed: 15279811
MD Comput. 1997 Jul-Aug;14(4):306-17
pubmed: 9230594
BMC Pediatr. 2019 Oct 11;19(1):346
pubmed: 31604460
J Clin Immunol. 2019 Jan;39(1):81-89
pubmed: 30607663
Front Immunol. 2020 Sep 29;11:1954
pubmed: 33117328
J Allergy Clin Immunol. 2019 Jan;143(1):325-334.e2
pubmed: 29906526
Clin Immunol. 2016 Feb;163:75-83
pubmed: 26762768
Z Kinderheilkd. 1973 Dec 12;116(1):1-12
pubmed: 4771703
J Immunol. 2006 Apr 15;176(8):5060-8
pubmed: 16585603
Front Immunol. 2017 Jul 17;8:798
pubmed: 28769923
Front Immunol. 2022 May 03;13:869728
pubmed: 35592332
Hum Genet. 2020 Jun;139(6-7):745-757
pubmed: 32067110
Mol Cell. 2001 Dec;8(6):1187-96
pubmed: 11779495
J Clin Immunol. 2018 Aug;38(6):646-655
pubmed: 30046960
J Allergy Clin Immunol. 2017 Dec;140(6):1739-1743.e7
pubmed: 28864286
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10037-41
pubmed: 11517324
Am J Med Genet A. 2007 Apr 1;143A(7):742-5
pubmed: 17345618
Curr Biol. 1999 Jul 1;9(13):699-702
pubmed: 10395545
Clin Immunol. 2015 Oct;160(2):255-60
pubmed: 26172957
Mol Cell. 2001 Dec;8(6):1175-85
pubmed: 11779494
Nat Commun. 2018 Jul 6;9(1):2642
pubmed: 29980672
Radiol Case Rep. 2021 Aug 01;16(10):2890-2893
pubmed: 34401020
Blood. 2018 Feb 15;131(7):717-732
pubmed: 29146883
J Clin Invest. 2006 Jan;116(1):137-45
pubmed: 16357942
Cell Death Dis. 2018 May 31;9(6):662
pubmed: 29855463
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
J Allergy Clin Immunol. 2018 Jan;141(1):322-328.e10
pubmed: 28392333
Orphanet J Rare Dis. 2016 Oct 7;11(1):137
pubmed: 27717373
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
J Biol Chem. 2001 Aug 17;276(33):31124-32
pubmed: 11349135
J Med Genet. 1994 Feb;31(2):148-9
pubmed: 8182723
Hum Mutat. 2013 Dec;34(12):1611-4
pubmed: 24027040
BMC Pediatr. 2022 Oct 11;22(1):588
pubmed: 36221079
J Chem Inf Model. 2014 Jul 28;54(7):1951-62
pubmed: 24850022
PLoS One. 2013;8(1):e54389
pubmed: 23372718
Am J Med Genet A. 2005 Sep 1;137A(3):283-7
pubmed: 16088910
J Allergy Clin Immunol Pract. 2023 Jan;11(1):107-115
pubmed: 36610755
Hum Mol Genet. 2004 Oct 15;13(20):2369-76
pubmed: 15333585
Nat Rev Mol Cell Biol. 2014 Jan;15(1):7-18
pubmed: 24326623
Orphanet J Rare Dis. 2020 May 29;15(1):131
pubmed: 32471509
J Am Chem Soc. 2015 Apr 8;137(13):4300-3
pubmed: 25794270
Immunity. 2018 Feb 20;48(2):202-213
pubmed: 29466753
Lancet. 2009 Sep 12;374(9693):912-20
pubmed: 19729196
J Clin Immunol. 2022 Oct;42(7):1473-1507
pubmed: 35748970
Eur J Immunol. 2006 Jan;36(1):224-35
pubmed: 16358361
J Immunol. 2014 Feb 1;192(3):867-74
pubmed: 24376267
Pediatr Allergy Immunol. 2017 May;28(3):298-303
pubmed: 28039949
BMC Med Genet. 2016 Nov 17;17(1):84
pubmed: 27855655
J Clin Immunol. 2019 Jan;39(1):99-105
pubmed: 30617623
Proc Natl Acad Sci U S A. 1990 Nov;87(21):8350-4
pubmed: 1700429
J Biol Chem. 1998 Mar 6;273(10):5858-68
pubmed: 9488723

Auteurs

Annaïse J Jauch (AJ)

Immunodeficiency Laboratory, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.

Olivier Bignucolo (O)

Swiss Institute of Bioinformatics, Basel, Switzerland.

Sayuri Seki (S)

AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.

Marie Ghraichy (M)

Division of Immunology and Children's Research Center, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland.

Ottavia M Delmonte (OM)

Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.

Valentin von Niederhäusern (V)

Division of Immunology and Children's Research Center, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland.

Rebecca Higgins (R)

Division of Dermatology and Dermatology Laboratory, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.

Adhideb Ghosh (A)

Division of Dermatology and Dermatology Laboratory, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland; Competence Center for Personalized Medicine, University of Zürich/Eidgenössische Technische Hochschule, Zurich, Switzerland.

Masako Nishizawa (M)

AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.

Mariko Tanaka (M)

Department of Pathology, The University of Tokyo, Tokyo, Japan.

Adrian Baldrich (A)

Immunodeficiency Laboratory, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.

Julius Köppen (J)

Immunodeficiency Laboratory, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.

Julia R Hirsiger (JR)

Translational Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.

Robin Hupfer (R)

Immunodeficiency Laboratory, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.

Stephan Ehl (S)

Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty for Medicine, University of Freiburg, Freiburg, Germany.

Anne Rensing-Ehl (A)

Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty for Medicine, University of Freiburg, Freiburg, Germany.

Helmut Hopfer (H)

Institute for Pathology, University Hospital Basel, Basel, Switzerland.

Spasenija Savic Prince (SS)

Institute for Pathology, University Hospital Basel, Basel, Switzerland.

Stephen R Daley (SR)

Centre for Immunology and Infection Control, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Queensland.

Florian A Marquardsen (FA)

Immunodeficiency Laboratory, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.

Benedikt J Meyer (BJ)

Immunodeficiency Laboratory, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.

Michael Tamm (M)

Department of Pneumology, University Hospital Basel, Basel, Switzerland.

Thomas D Daikeler (TD)

Department of Rheumatology, University Hospital Basel, Basel, Switzerland; University Center for Immunology, University Hospital Basel, Basel, Switzerland.

Tamara Diesch (T)

Division of Pediatric Oncology/Hematology, University Children's Hospital Basel, Basel, Switzerland.

Thomas Kühne (T)

Division of Pediatric Oncology/Hematology, University Children's Hospital Basel, Basel, Switzerland.

Arthur Helbling (A)

Division of Allergology and clinical Immunology, Department of Pneumology and Allergology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Caroline Berkemeier (C)

Division Medical Immunology, Laboratory Medicine, University of Basel and University Hospital of Basel, Basel, Switzerland.

Ingmar Heijnen (I)

Division Medical Immunology, Laboratory Medicine, University of Basel and University Hospital of Basel, Basel, Switzerland.

Alexander A Navarini (AA)

Division of Dermatology and Dermatology Laboratory, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland; University Center for Immunology, University Hospital Basel, Basel, Switzerland.

Johannes Trück (J)

Division of Immunology and Children's Research Center, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland.

Jean-Pierre de Villartay (JP)

Laboratory of Genome Dynamics in the Immune System, Institut National de la Santé et de la Recherche Médicale Unité Mixte de Recherché 1163, Université Paris Descartes Sorbonne Paris Cité, Institut Imagine, Paris, France.

Annette Oxenius (A)

Institute of Microbiology, Eidgenössische Technische Hochschule, Zurich, Switzerland.

Christoph T Berger (CT)

Translational Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland; University Center for Immunology, University Hospital Basel, Basel, Switzerland.

Christoph Hess (C)

University Center for Immunology, University Hospital Basel, Basel, Switzerland; Immunobiology Laboratory, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.

Luigi D Notarangelo (LD)

Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.

Hiroyuki Yamamoto (H)

Immunodeficiency Laboratory, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland; AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan. Electronic address: h-yamato@niid.go.jp.

Mike Recher (M)

Immunodeficiency Laboratory, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland; University Center for Immunology, University Hospital Basel, Basel, Switzerland. Electronic address: mike.recher@usb.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH